GlaxoSmithKline Recalls Weight Loss Drug Alli® due to Possible Product Tampering
CNN reports that the British company GlaxoSmithKline has recalled Alli®, an over-the-counter weight loss drug, due to possible product tampering. The company said that “a range of tablets and capsules of various shapes and colors were reported to be found inside bottles [and] [a]dditionally, some bottles inside the outer carton were missing labels and had tamper-evident seals that were not authentic.”
Deborah Bolding, spokeswoman for GlaxoSmithKline, said that 20 tampered bottles were reported to the company by 12 different customers. Bolding added, “We have received no reports of serious illness from the consumers who have reported these tampered products.” However, GlaxoSmithKline is conducting an investigation with the Food and Drug Administration (FDA).
This is not the first time the FDA has raised issues with the weight-loss drug Alli®. On May 26 2010, the FDA issued a Drug Safety Communication warning consumers about rare reports of severe liver injury associated with the over-the-counter diet drug Alli®. And before that in January 2010, the FDA warned that a counterfeit version of Alli® was being sold on the Internet that could potentially harm consumers.
The choice of a lawyer is an important decision and should not be based solely on advertisements.